Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 6.880

-0.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who wrote (1913)	2/13/2008 12:46:15 PM
From: richardred	Read Replies (1) of 7242

BNT -News today. The reason for the recent strength. Bentley to Sell Generic Prilosec in EU Wednesday February 13, 9:57 am ET Bentley Pharma Gets European OK to Sell Generic Version of AstraZeneca's Drug Prilosec EXETER, N.H. (AP) -- Bentley Pharmaceuticals Inc., which markets generic and branded drug products, said Wednesday its European subsidiaries received approvals to market a generic version of AstraZeneca PLC's heartburn drug Prilosec in Europe. Bentley said the approvals apply to the 10, 20 and 40 milligram dosage levels of omeprazole, called Prilosec in the U.S. and Losec in Europe, throughout the European Union. Bentley's subsidiaries expect to supply omeprazole to their licensees in the major markets of Germany and Italy, as well as other EU countries. The manufacture and supply of the finished products will be through Bentley's subsidiary, Laboratorios Belmac. The company plans to begin supplying omeprazole to licensees during the first quarter of 2008. British drug maker AstraZeneca said Losec/Prilosec generated $1.14 billion in 2007 worldwide sales. Shares of Bentley rose 38 cents, or 2.5 percent, to $15.64 in morning trading. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next